Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Sep 11, 2020

BUY
$73.37 - $98.18 $146,740 - $196,360
2,000 New
2,000 $0
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $146,740 - $196,360
-2,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $129,000 - $195,580
2,000 New
2,000 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.